These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16416038)

  • 21. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Cushing's syndrome - Endogenous hypercortisolemia on cardiovascular autonomic functions.
    Jyotsna VP; Naseer A; Sreenivas V; Gupta N; Deepak KK
    Auton Neurosci; 2011 Feb; 160(1-2):99-102. PubMed ID: 21177144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical consequences of Cushing's syndrome.
    Valassi E; Crespo I; Santos A; Webb SM
    Pituitary; 2012 Sep; 15(3):319-29. PubMed ID: 22527617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complications of Cushing's syndrome: state of the art.
    Pivonello R; Isidori AM; De Martino MC; Newell-Price J; Biller BM; Colao A
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):611-29. PubMed ID: 27177728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cushing syndrome: When to suspect and how to confirm?].
    Guignat L; Bertherat J
    Presse Med; 2014 Apr; 43(4 Pt 1):366-75. PubMed ID: 24656297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.
    Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R;
    J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment.
    Akaza I; Yoshimoto T; Iwashima F; Nakayama C; Doi M; Izumiyama H; Hirata Y
    Hypertens Res; 2011 Oct; 34(10):1111-5. PubMed ID: 21775997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
    Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
    Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular consequences of cortisol excess.
    Whitworth JA; Williamson PM; Mangos G; Kelly JJ
    Vasc Health Risk Manag; 2005; 1(4):291-9. PubMed ID: 17315601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and complications of Cushing's syndrome: a consensus statement.
    Arnaldi G; Angeli A; Atkinson AB; Bertagna X; Cavagnini F; Chrousos GP; Fava GA; Findling JW; Gaillard RC; Grossman AB; Kola B; Lacroix A; Mancini T; Mantero F; Newell-Price J; Nieman LK; Sonino N; Vance ML; Giustina A; Boscaro M
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5593-602. PubMed ID: 14671138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incompatibility between fasting and postprandial plasma glucose in patients with Cushing's syndrome.
    Otsuki M; Kitamura T; Tamada D; Tabuchi Y; Mukai K; Morita S; Kasayama S; Shimomura I; Koga M
    Endocr J; 2016 Nov; 63(11):1017-1023. PubMed ID: 27498594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Glucose tolerance and manifested diabetes mellitus in patients with Itsenko-Cushing's syndrome].
    Galiullin FL
    Probl Endokrinol (Mosk); 1971; 17(3):23-7. PubMed ID: 5138405
    [No Abstract]   [Full Text] [Related]  

  • 38. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
    Koracevic G; Stojkovic M; Lovic D; Pavlovic M; Kostic T; Kutlesic M; Micic S; Koracevic M; Djordjevic M
    Curr Vasc Pharmacol; 2020; 18(1):12-24. PubMed ID: 30289080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].
    Luton JP; Richard C; Laudat MH; Pinon JC; Bricaire H
    Nouv Presse Med; 1982 Sep; 11(36):2693-8. PubMed ID: 7145656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy.
    Terzolo M; Reimondo G; Chiodini I; Castello R; Giordano R; Ciccarelli E; Limone P; Crivellaro C; Martinelli I; Montini M; Disoteo O; Ambrosi B; Lanzi R; Arosio M; Senni S; Balestrieri A; Solaroli E; Madeo B; De Giovanni R; Strollo F; Battista R; Scorsone A; Giagulli VA; Collura D; Scillitani A; Cozzi R; Faustini-Fustini M; Pia A; Rinaldi R; Allasino B; Peraga G; Tassone F; Garofalo P; Papini E; Borretta G
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3467-75. PubMed ID: 22767639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.